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Achilles tendinopathy is a painful inflammatory condition characterized by swelling, stiffness
and reduced function of the Achilles tendon. Kager’s fat pad is an adipose tissue located in
the area anterior to the Achilles tendon. Observations reveal a close physical interplay be-
tween Kager’s fat pad and its surrounding structures during movement of the ankle, sug-
gesting that Kager’s fat pad may stabilize and protect the mechanical function of the ankle
joint.
Aim
The aim of this study was to characterize whether Achilles tendinopathy was accompanied
by changes in expression of inflammatory markers and metabolic enzymes in Kager’s fat
pad.
Methods
A biopsy was taken from Kager’s fat pad from 31 patients with chronic Achilles tendinopathy
and from 13 healthy individuals. Gene expression was measured by reverse transcription-
quantitative PCR. Focus was on genes related to inflammation and lipid metabolism.
Results
Expression of the majority of analyzed inflammatory marker genes was increased in pa-
tients with Achilles tendinopathy compared to that in healthy controls. Expression patterns
of the patient group were consistent with reduced lipolysis and increased fatty acid β-oxida-
tion. In the fat pad, the pain-signaling neuropeptide substance P was found to be present in
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one third of the subjects in the Achilles tendinopathy group but in none of the healthy
controls.
Conclusion
Gene expression changes in Achilles tendinopathy patient samples were consistent with
Kager’s fat pad being more inflamed than in the healthy control group. Additionally, the re-
sults indicate an altered lipid metabolism in Kager’s fat pad of Achilles tendinopathy
patients.
Introduction
Adipose tissue has multiple functions including insulation and structural support, but is first
and foremost a key metabolic tissue with profound influence on whole-body homeostasis [1].
Two main types of adipose tissue exist: white adipose tissue, which is the largest energy store of
the body, and brown adipose tissue that is specialized in energy dissipation through uncoupled
respiration. Adipocytes secrete adipokines, cytokines, and growth factors, acting in endocrine,
paracrine or autocrine manners, thereby influencing appetite, insulin sensitivity, metabolism of
other tissues and processes like healing, inflammation and tissue degradation [1–4].
Kager’s fat pad, also described as the pre-Achilles fat pad, is a sharply enclosed radiolucent
triangle delineated by the flexor halluces longus muscle and tendon (anterior border), the supe-
rior cortex of the calcaneus (inferior border) and the Achilles tendon (posterior border) [5]. It
has been suggested that the flexor halluces longus part of Kager’s fat pad contributes to moving
the bursal wedge during plantar flexion, that the Achilles-associated part protects blood vessels
passing through it to supply the Achilles tendon, and that the region near the bursal wedge
minimizes pressure changes in the retrocalcaneal bursa [6]. Changes in Kager’s fat pad have
been observed in a variety of conditions, including cortical destruction of the calcaneus mediat-
ed by either a tumor or infection, Os trigonum syndrome [5], accessory soleus muscle [7] and
fibroma of the tendon sheath [8]. Radiographical changes in Kager’s fat pad can signal the pres-
ence of abnormality [5]. Abnormal conditions involving the posterior ankle may result in in-
creased and ill-defined soft tissue density in Kager’s fat pad or the obliteration of its borders.
Additionally, patients with chronic pain in the Achilles tendon, Achilles tendinopathy (AT),
often show an increased soft tissue density simultaneously with an increased thickness of the
Achilles tendon. Despite the common occurrence of pain symptoms and soft tissue alterations
in Kager’s fat pad, this region has not been investigated, and detailed knowledge of its role in
the pathophysiology of the Achilles tendon is sparse.
Another fat pad that has received more attention is the infrapatellar fat pad (IFP), also
known as Hoffa’s fat pad. Chronic edema of the IFP is the key pathology of Hoffa’s disease, the
edema leading to soft tissue impingement, ischemia, and in the long-term lipomatous tissue ne-
crosis [9,10]. IFP contains inflammatory cells and is a source of adipokines, cytokines and
growth factors, which might impact disease [11]. Several inflammatory mediators secreted
from adipose tissue, including interleukin-1α (IL-1α), IL-1β, IL-6, IL-10, tumor necrosis fac-
tor-α (TNF-α), monocyte chemotactic protein-1 (MCP1) and prostaglandin E2, have been
shown to be involved in joint diseases [12–14]. Furthermore, one study showed that adiponec-
tin (ADIPOQ) induces matrix metalloproteinase-1 and IL-6 expression in synovial fibroblasts
[15]. Thus, ADIPOQmight have pro-inflammatory functions in joint diseases [16]. These find-
ings underline that, besides being a reservoir for storage of excess calories, adipose tissue plays
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an important role in the process of inflammation [12]. Whether these inflammatory cells and
mediators are also present in Kager’s fat pad and whether the potential inflammatory state of
the fat pad may influence pain and other symptoms of AT patients is still unclear.
The aim of the present study was to analyze gene expression changes in Kager’s fat pad of
chronic AT patients. Our focus was on genes encoding macrophage markers, adipokines, cyto-
kines and growth factors as well as genes involved in lipid and energy metabolism. We provide
evidence that patient-derived fat pads display a remarkable inflammatory profile and altered
expression of a number of metabolism-related genes.
Materials and Methods
Subjects
The subjects were fully informed and gave their written consent to participate in adherence to
the declaration of Helsinki. The study was approved by the Ethical Committee of the capital re-
gion of Copenhagen, Denmark (H-1-2009-114). Thirty-one AT patients were recruited for this
study. One AT patient had to be excluded due to failure in the process from biopsy to cDNA.
In addition, 13 healthy control subjects were recruited. The AT patients were all recreational
athletes or persons with physical work with a long history of chronic Achilles tendon pain (sub-
ject characteristics are shown in Table 1), on whom conventional conservative treatments, like
eccentric training programs, non-steroidal anti-inflammatory drug medication, and corticoste-
roid injections, had been tried with no lasting effect. A window of at least 6 months between
the most recent last intake of these medications and the present study was ensured in all cases.
Control subjects had no previous history of symptoms of Achilles tendon or Kager’s fat pad
pain sensation and were without acute or chronic diseases. All AT patients were recruited from
the Diagnostic Centre, Silkeborg Regional Hospital, Denmark.
Design and biopsy procedure
To ensure that all participants were in a resting state, they were asked to abstain from any kind
of exercise 24 h prior to the experiment. After arrival to the clinic, body weight and height were
recorded before preparation for biopsy. A biopsy of Kager’s fat pad was taken from the subjects
placed in a supine position. The subjects were locally anesthetized under ultrasound guidance
with 2 ml 1% lidocaine in the peritendinous space from both the medial and lateral side of the
tendon. An ultrasound guided biopsy of Kager’s fat pad was taken from the middle of the
Kager’s triangle with a semi-automatic biopsy needle [14 GA 9 cm (Angiotech)]. The samples
were snap-frozen in liquid nitrogen and stored at -80°C for later RNA isolation.
Table 1. Subject characteristics.
Subjects Sex Age Height Weight BMI Duration of symptoms
(n) (F/M) (years) (m) (kg) (mo.)
Controls 13 7/6 29 1.73 71.1 23.5 _
(19–48) (1.6–1.88) (51–94) (19.9–29.0)
Patients 30 10/20 49 1.78 91.2 28.8 40
(31–67) (1.6–1.96) (66.7–122) (22.5–38.5) (9–156)
Values are presented as mean (min—max).
F, female; M, male; BMI, body mass index; mo., months.
doi:10.1371/journal.pone.0127811.t001
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Tissue lysis and homogenization
Adipose tissue biopsies were kept on dry ice during most of the lysis procedure. The tissue was
rinsed shortly in phosphate-buffered saline (Life Technologies) to remove excess blood, placed
in 2-ml capped micro tubes (Sarstedt) with ceramic beads (Precellys) on dry ice. TRI Reagent
(Sigma-Aldrich) (1 ml) was quickly added and the tissue was lysed and homogenized using a
Precellys 24 instrument (Bertin Technologies). All lysates were quickly transferred to Eppen-
dorf tubes on dry ice and stored at -80°C until RNA was isolated.
RNA purification and reverse transcription
Total RNA was isolated according to the instructions of the manufacturer (Sigma-Aldrich).
Briefly, after homogenization in TRI Reagent, total RNA was isolated by phase-separation after
addition of 0.2 ml chloroform. RNA was precipitated from the aqueous phase by addition of
0.5 ml isopropanol. The resulting RNA pellet was washed in 1 ml 75% ethanol and dissolved in
10 μl diethyl pyrocarbonate-treated H2O and the RNA samples were frozen at -80°C. Reverse
transcription was carried out essentially as described [17]. Briefly, total RNA was treated with
RQ1 DNase (Promega) for 30 min at 37°C, followed by heat inactivation for 5 min at 75°C. Re-
actions were performed in 25 μl containing 1x 1st Strand Buffer (Life Technologies), 0.1 μg ran-
dom hexamers (Bioline), 0.9 mM of each dNTP (Sigma-Aldrich), 20 units of RNaseOUT
(Sigma-Aldrich), 1 μg of total DNase-treated RNA and 200 units of Moloney murine leukaemia
virus reverse transcriptase (Life Technologies). Reactions were left for 10 min at room tempera-
ture, followed by incubation at 37°C for 1 h. After cDNA synthesis, reactions were diluted with
50 μl of nuclease-free water and frozen at -80°C.
Reverse transcription-quantitative polymerase chain reaction (RT-
qPCR)
Diluted cDNA (1.5 μl) in a final PCR mixture volume of 20 μl, was analyzed by RT-qPCR
using the Stratagene Mx3000P QPCR System (Agilent Technologies). Besides the cDNA, each
PCR mixture contained 10 μl of 2x SensiFAST SYBR Lo-Rox Kit (Bioline), 2 pmol of each
primer (forward and reverse) (0.1 μM, final concentration) and UltraPURE H2O. PCR was car-
ried out in 96-well plates, where each sample was analyzed in duplicate using the following cy-
cling conditions: 95°C for 10 min, then 40 cycles of 95°C for 15 s, 55°C for 30 s, and 72°C for
15 s, followed by 95°C for 1 min, 60°C for 30 s, and 95°C for 30 s. Target gene mRNA expres-
sion was normalized to the stably expressed TATA-binding protein (TBP) mRNA using the
formula 0.5^(target Ct—normalizer Ct). The normalized values are designated the relative
mRNA expression in the present study. Primers used for RT-qPCR are listed in S1 Table. Prim-
ers were designed using the Primer-BLAST tool from NCBI and were, when possible, designed
to span an exon-exon junction. Primer efficacy was validated by serial dilution of template and
melting curve analysis was used to confirm the presence of a single amplicon.
Statistics
The statistical software SAS version 9.3 was used together with SAS Enterprise Guide version
5.1 for statistical analyses and model controls. An unpaired two-tailed Student’s t-test was used
to compare the control group with the AT patient group. The test was performed on the log2--
transformed relative mRNA expression, which was found to be normally distributed in all
cases, except for citrate synthase (CS), monoacylglycerol lipase (MGL), hormone-sensitive li-
pase (HSL), adipose triglyceride lipase (ATGL), and interleukin-1 receptor 1 (IL-1R1), for
which the untransformed relative mRNA expression was normally distributed. A p-value of
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less than 0.05 was considered significant. The respective levels of significance can be found in
S2 Table together with the mean relative mRNA expression values for the control group and
the patient group. The mean expression value in S2 Table was back-transformed if the test was
carried out on log2-transformed data. Figs 1, 2 and 3 show the untransformed mean relative
mRNA expression values with SEM values. Mean relative mRNA expression for the control
group was set to 1 and the other values were adjusted accordingly. The general linear model
was used to test for an effect of BMI or age on gene expression levels and to test for an interac-
tion between BMI or age and the health status (AT patient or healthy control subject).
Results
Expression of 27 genes was analyzed in 30 AT patients and 13 control subjects. The gene tar-
gets were selected mainly to analyze three different physiological functions: inflammation, lipid
and energy metabolism, and the results, stratified this way, are shown below.
Inflammation
The mRNA expression data are shown in Fig 1 and corresponding p-values in S2 Table. Ex-
pression of TNF-α, IL-1R1, IL-6, IL-10,MCP1 and the macrophage marker cluster of
Fig 1. Inflammatory markers.mRNA levels of the inflammatory markers TNF-α, IL-1R1, IL-6, IL-10 andMCP1 and of the macrophage markerCD68 were
significantly elevated in the Kager’s fat pad of AT patients (n = 30) compared to healthy CON subjects (n = 13). The expression of target gene mRNA was
normalized to the expression of TBPmRNA. Normalized mRNA expression for the control subjects was set to 1. * p < 0.05 (compared to CON). TNF-α,
tumor necrosis factor-α; IL-1R1, interleukin-1 receptor 1; IL-6, interleukin-6; IL-10, interleukin-10;MCP1, monocyte chemotactant protein-1;CD68, cluster of
differentiation 68; CON, control; AT, Achilles tendinopathy; TBP, TATA-binding protein.
doi:10.1371/journal.pone.0127811.g001
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differentiation 68 (CD68) was 1.4–4.0 fold higher in AT patients when compared to the control
subjects (Fig 1). The tachykinin, precursor 1 gene (TAC1), encoding substance P among other
proteins, was detectable in 11 subjects, all of them AT patients, albeit expression in these was
very low (Ct-values 36.2–39.0). No difference between the AT and control groups was found
for mRNA levels of EGF-like module-containing mucin-like hormone receptor-like 1 (EMR1),
IL-1β, and resistin (RETN) (S2 Table).
Lipid metabolism
The mRNA expression of ATGL, HSL,MGL, and acetyl-CoA carboxylase 2 (ACC2) was mod-
estly but significantly 1.3–1.6 fold lower in AT patients compared to the control subjects. In
contrast, carnitine-acylcarnitine translocase (CACT) and carnitine palmitoyltransferase
(CPT2) showed a significantly 1.2–1.3 fold higher mRNA expression in AT patients when com-
pared to the control subjects (Fig 2, S2 Table). No difference was found in the mRNA expres-
sion of ACC1, CPT1B, and fatty acid synthase (FASN), when comparing the AT patients with
the control subjects (S2 Table).
Fig 2. Lipid metabolism.mRNA levels of ATGL, HSL,MGL, and ACC2 were significantly lower in Kager’s fat pad of AT patients (n = 30) compared to
healthy CON subjects (n = 13, except ATGL andHSL: n = 12), while the mRNA expression ofCACT andCPT2was significantly elevated. The expression of
target gene mRNA was normalized to the expression of TBPmRNA. Normalized mRNA expression for the control subjects was set to 1. * p < 0.05
(compared to CON). ATGL, adipose triglyceride lipase;HSL, hormone-sensitive lipase;MGL, monoacylglycerol lipase; ACC2, acetyl-CoA carboxylase 2; AT,
Achilles tendinopathy; CON, control; CACT, carnitine-acylcarnitine translocase; CPT2, carnitine palmitoyltransferase 2; TBP, TATA-binding protein.
doi:10.1371/journal.pone.0127811.g002
Kager's Fat Pad in Achilles Tendinopathy
PLOS ONE | DOI:10.1371/journal.pone.0127811 May 21, 2015 6 / 13
Energy metabolism, ADIPOQ and GLUT4
The mRNA expression of CS, glucose transporter 4 (GLUT4), and ADIPOQ was 1.4–3.9 fold
lower, while the mRNA expression of the retinoblastoma 1 gene (RB1) was 1.3 fold higher in
AT patients compared to the control subjects (Fig 3). No difference was found in the mRNA
expression of leptin (LEP), glucose-6-phosphate dehydrogenase (G6PD), and uncoupling pro-
tein 1 (UCP1) when comparing the AT patients with the control subjects (S2 Table).
The effect of BMI on gene expression
The AT patients had a higher body mass index (BMI) than the healthy controls (see Table 1).
We therefore analyzed the potential effect of BMI on gene expression. Seven of the 16 genes
displaying a significant differential expression between AT patients and control subjects re-
vealed a significant effect of BMI on gene expression. These genes were ADIPOQ, CACT,
CD68, CS, GLUT4, IL-10, and IL-1R1. To probe if the differential expression of the seven genes
between the two groups was due to differences in BMI, expression levels were tested for differ-
ences between the AT patients and the control subjects when simultaneously taking BMI into
account. The effect of BMI disappeared for all of the seven genes when the test included infor-
mation about the health status (AT patient or control subject), and for five of the seven genes,
ADIPOQ, CD68, CS, GLUT4, and IL-10, there was still a significant difference in expression
level between AT patients and healthy controls.
Fig 3. Energymetabolism,GLUT4 and ADIPOQ.mRNA levels of CS,GLUT4 and ADIPOQwere significantly lower, and the mRNA expression of RB1 was
significantly elevated, in the Kager’s fat pad of AT patients (n = 30) compared to healthy CON subjects (n = 13). The expression of target gene mRNAwas
normalized to the expression of TBPmRNA. Normalized mRNA expression for the control subjects was set to 1. * p < 0.05 (compared to CON).CS, citrate
synthase;GLUT4, glucose transporter 4; ADIPOQ, adiponectin; RB1, retinoblastoma 1; AT, Achilles tendinopathy; CON, control; TBP, TATA-binding protein.
doi:10.1371/journal.pone.0127811.g003
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The effect of age on gene expression
On average, the AT patients were older than the healthy controls (see Table 1). Therefore, the
possible effect of age on gene expression was analyzed. Expression of six of the 16 genes display-
ing a significant differential expression between AT patients and control subjects were signifi-
cantly influenced by age. These genes wereMGL, RB1, CD68, CS, GLUT4, and IL-10. To
determine if the differential expression between the two groups was due to differences in age, ex-
pression levels of the six age-affected genes were tested for differences between AT patients and
control subjects when simultaneously taking age into account. The possible interaction between
age and health status was also tested. The effect of age disappeared for five of the six genes when
the test included information about health status, and for the last gene, RB1, an interaction was
found between age and health status. In other words, RB1 was differentially expressed between
AT patients and control subjects but the difference depended on the age of the subject. Except
forMGL, CD68, and CS, there was still a significant difference in mRNA expression between
control subjects and AT patients when accounting for age, and for the mentioned non-signifi-
cant genes, the difference was still nearly significant (p-values 0.0561–0.0677).
Discussion
To the best of our knowledge we here report the first investigation of gene expression changes
in Kager’s fat pad of AT patients. The main finding of the present study is an increased expres-
sion of inflammatory marker genes as well as altered expression of genes involved in lipid and
energy metabolism in AT patients.
Inflammation
We have previously investigated several inflammatory markers in Achilles tendon tissue and
have observed that inflammation was absent in tendon tissue of chronic AT patients [18,19].
This result concurs with the generally accepted notion that tendinopathy is an ongoing tendon
degenerative process [20–22]. Nevertheless, despite the absence of tendon inflammation, corti-
costeroid injections are often used as a treatment, providing a short-term relief of symptoms
[23]. The corticosteroid-mediated relief of symptoms is difficult to explain if tendinopathy is
considered solely a degenerative process [24] and indicates that inflammation plays a role.
Since it is well known that adipose tissue in itself has immunological functions [25] and has
been proposed to play important roles in other tendon pathologies including Hoffa’s disease
[26] and osteoarthritis [27], we considered it important to investigate the inflammatory status
of Kager’s fat pad in chronic AT patients. We provide evidence for an inflammatory phenotype
in the Kager’s fat pad of patients, as documented by increased expression of TNF-α, IL-1R1, IL-
6, IL-10,MCP1 and CD68. The existence of paracrine interactions between the inflammatory
response of tenocytes in the tendon and adipocytes in the fat pad is likely. However, in the pres-
ent study we analyzed the inflammatory markers of the Kager’s fat pad only, and our data
therefore cannot provide definitive conclusions about this possibility. ADIPOQ has been sug-
gested to be pro-inflammatory in joint diseases [16], but in our study, we find lower ADIPOQ
mRNA levels in patients than in healthy controls, arguing against a pro-inflammatory function
in AT. A previous study by Shaw et al. identified CD68 positive cells in the retromalleolar fat
pad in rats using immunohistochemistry, and suggested that these cells might play a role com-
bating infection and/or removal of cell debris [28]. Another reason for the presence of macro-
phages and inflammatory markers could be fat tissue fibrosis. It has been shown that the
development of fibrosis of adipose tissue in obesity is tightly associated with tissue inflamma-
tion and the infiltration of macrophages [29] and mast cells [30]. In addition, it has been
shown that increased collagen formation in the IFP might contribute to the development of
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synovial fibrosis [31]. Whether fibrosis is present in Kager’s fat pad of AT patients has yet to be
investigated. It has been suggested that the fat pads are filling dead spaces in joints and thereby
maintaining the joint cavity and promoting efficient lubrication [32]. The tip of Kager’s fat pad
is associated with the Achilles tendon and minimizes pressure changes in the bursa by moving
in and out of the retrocalcaneal bursa during plantar and dorsiflexion of the foot [6]. However,
in case of fat pad hypertrophy, the space filling properties might contribute to symptoms of
tendinopathy [33]. It has been shown previously that the size of the IFP is associated with
patellar tendinopathy. Magnetic resonance imaging showed that patellar tendinopathy pa-
tients had a significantly larger fat pad compared to the control subjects when controlled for
height [34]. Whether the size of Kager’s fat pad is increased in AT patients needs further
investigation.
In the knee joint there is an intimate relationship between the patellar tendon and the fat
pad, and a shared neurovascular supply has been observed [35]. Kager’s fat pad is related to the
Achilles tendon in a similar manner [6]. In patellar tendinopathy, neurovascular infiltration
into the patellar tendon has been observed [36]. Neurovascular ingrowth is associated with ten-
don pathology and pain. In addition, the IFP has been shown to have a nociceptive function in
the anterior knee pain syndrome [37]. Shaw et al. also identified nerve fibers and the nocicep-
tive marker substance P in the fat tissue [28]. Another study showed an increased number of
nociceptive fibers in ‘jumpers knee’ patients [38]. Since there is growing evidence that the fat
pad is involved in pain mechanisms of tendon pathologies, it is relevant to mention that ex-
pression of the TAC1 gene, encoding substance P, was below the detection limit in most sub-
jects of the present study. However, TAC1mRNA was detectable in about one third (n = 11) of
the AT patients, but could not be detected in any healthy control subjects. This may indicate
that Kager’s fat pad mediates pain in Achilles tendinopathy.
Lipid and energy metabolism
In the present study, gene expression was analyzed in Kager’s fat pad only. Reduced expression
of ATGL, HSL andMGL in Kager’s fat pad of AT patients as compared to control subjects indi-
cates decreased lipolysis in the patient group [39]. CACT and CPT2mRNAs were increased in
AT patients suggesting that the Kager’s fat pad of patients has an increased capacity for β-oxi-
dation. By contrast, CPT1B, catalyzing the first and rate-limiting step of transport of fatty acids
into mitochondria [40], showed no difference in expression between the AT patients and the
control group. ACC2 expression was lower in AT patients, indicative of diminished malonyl-
CoA synthesis and thereby higher activity of CPT1B in AT patients, despite unchanged expres-
sion levels [41]. Combined, this is supportive of increased β-oxidation in Kager’s fat pad of AT
patients. The gene expression analysis thus creates an apparent paradox, as lipolysis appears to
be decreased, whereas fatty acid oxidation appears to increase in AT patients. Although mRNA
levels need not reflect enzyme activities, one possible explanation is that in Kager’s fat pad
from AT patients, more fatty acid are taken up from the circulation. This could be studied by
measuring levels of fatty acid transport proteins. In AT patients, we found a decrease in expres-
sion of GLUT4, suggesting decreased insulin-stimulated glucose uptake in Kager’s fad pad-resi-
dent adipocytes of AT patients. Therefore, it remains possible that Kager’s fad pad of AT
patients metabolizes relatively more fatty acids and less glucose than in healthy controls.
In terms of energy metabolism, we detected decreased expression of CS and increased ex-
pression of RB1 in the Kager’s fat pad of AT patients compared to healthy controls. RB1 is a
tumor suppressor, but is also an established inhibitor of oxidative metabolism in both white
and brown adipose tissue [42,43]. Therefore, these data suggest that oxidative metabolism is
lower in the fat pad of AT patients. RB1 is also inhibiting expression of the brown fat-specific
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UCP1 gene [42,43]. The very low expression of UCP1mRNA strongly suggests that Kager’s fat
pad is a white adipose tissue depot.
The influence of BMI and age on gene expression
The possible effect of BMI and age on gene expression was analyzed. Of the 16 genes differen-
tially expressed between the healthy control group and the AT patients, seven genes were sig-
nificantly affected by BMI. For five of the seven genes, there was still a significant difference in
mRNA expression between control subjects and AT patients when accounting for BMI. Thus,
differences in BMI between the healthy control group and the AT patients could only explain
two out of 16 differentially expressed genes. With respect to age, six of the 16 genes differential-
ly expressed between healthy controls and AT patients were significantly influenced by age.
Three of the six genes still displayed differential expression with respect to health status when
accounting for age. Thus, differences in age between the healthy control group and the AT
group could only explain three out of 16 differentially expressed genes.
Limitations of the present study
A limitation of the present study is that gene expression was analyzed only by RT-qPCR. Obvi-
ously, an altered mRNA level does not necessarily reflect a change in protein level or protein
activity. However, as very little tissue was available for analysis, we were limited to studying
gene regulation at the mRNA level. Another limitation is that differences in cell type composi-
tion of Kager’s fat pad between healthy control subjects and AT patients might have influenced
the outcome of our gene expression analysis. The inflammatory gene expression profile of AT
patients most likely means an increased prevalence of immune cells in their fat pad, which
again might have affected the relative expression of some of the metabolism-related
genes analyzed.
Conclusion
The contribution of Kager’s fat pad to Achilles tendinopathy is unknown. The present study re-
veals that Kager’s fat pad might play an important role in the pathology of disease. Expression
of several inflammatory markers was up-regulated in the Kager’s fat pad of AT patients. In ad-
dition, the gene expression data are consistent with substantial alterations in lipid and energy
metabolism of the fat pad of AT patients. Delineating the contribution of the inflammatory
state and the altered metabolism of Kager’s fat pad to Achilles tendinopathy requires more and
dedicated investigations.
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